Article info

PDF
Current understanding and management of pulmonary Langerhans cell histiocytosis

Authors

  • Robert Vassallo Departments of Medicine, Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA PubMed articlesGoogle scholar articles
  • Sergio Harari U.O. di Pneumologia e Terapia Semi-Intensiva Respiratoria “Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe“ Multimedica IRCCS, Milano, Italy PubMed articlesGoogle scholar articles
  • Abdellatif Tazi Department of Pulmonary Medicine, Saint-Louis Hospital, National Reference Center for Langerhans Cell Histiocytosis, University Paris Diderot, Sorbonne Paris Cite, Inserm UMR-1153 (CRESS), Biostatistics and Clinical Epidemiology Research Team (ECSTRA), Paris, Ile-de-France, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Robert Vassallo, Departments of Medicine, Division of Pulmonary and Critical Care Medicine, Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota 55905, USA; vassallo.robert{at}mayo.edu
View Full Text

Citation

Vassallo R, Harari S, Tazi A
Current understanding and management of pulmonary Langerhans cell histiocytosis

Publication history

  • Received 10 February 2017
  • Revised 10 May 2017
  • Accepted 15 May 2017
  • Published in print 7 July 2017.
  • Published online 8 July 2017.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.